Remedio names new CMO and CBO to drive growth

By AI, Created 11:39 AM UTC, May 20, 2026, /AGP/ – Remedio on May 6, 2026 appointed cybersecurity veterans Cindy Stanton as chief marketing officer and Mor Bikovsky as chief business officer as the company pushes to expand its autonomous exposure remediation platform globally. The hires come after a $65 million Series A and as Remedio says it now secures more than 3 million devices across over 300 enterprises.

Why it matters: - Remedio is trying to strengthen its position in autonomous exposure remediation, a category focused on fixing security issues instead of only detecting them. - The company is betting that senior go-to-market leadership will help convert product momentum into broader enterprise adoption. - The new appointments come after Remedio’s $65 million Series A and continued traction with large global customers.

What happened: - Remedio appointed Cynthia Stanton as chief marketing officer and Mor Bikovsky as chief business officer on May 6, 2026. - The company said both leaders will help drive its next phase of global growth in enterprise cybersecurity markets. - CEO Tal Kollender said Stanton and Bikovsky will help define and lead the category.

The details: - Stanton joins Remedio with more than 20 years of cybersecurity go-to-market leadership. - At Rapid7, Stanton led a 110-person global marketing organization as CMO. - Rapid7’s marketing function was shifted to full-funnel ARR accountability under Stanton. - Before becoming CMO at Rapid7, Stanton ran the Vulnerability Risk Management business unit. - Stanton’s prior role gave her direct exposure to customers trying to reduce risk at scale. - At Remedio, Stanton will lead product marketing, demand generation, brand and communications, and customer lifecycle marketing. - Bikovsky brings more than 15 years of cybersecurity experience. - Bikovsky has spent the past two years at Remedio. - Her background includes six years at Claroty building global strategic partnerships across critical infrastructure and industrial sectors. - At Claroty, Bikovsky helped define the Cyber-Physical Systems security category. - Bikovsky also served seven years in the Israel Defense Forces Intelligence Corps in elite technology units. - Remedio says its platform safely and automatically fixes misconfigurations and vulnerabilities across endpoints, servers, networking devices, and enterprise AI agents. - The company says its platform also enforces continuous compliance with zero disruption and instant rollback. - Remedio says it secures more than 3 million devices for more than 300 global enterprises, including Amazon, Colgate-Palmolive, and Ulta Beauty. - Remedio was bootstrapped to profitability by Kollender in 2019. - The company’s $65 million Series A was led by Bessemer Venture Partners, with participation from TLV Partners and Picture Capital. - More information is available in Remedio’s announcement.

Between the lines: - The hire of two executives with deep cybersecurity and category-building experience signals Remedio wants to move faster from product validation to market leadership. - Stanton’s and Bikovsky’s backgrounds suggest the company is prioritizing both demand generation and commercial partnerships. - Remedio is framing the business around a common security pain point: teams can spot risk, but still struggle to fix it at scale.

What’s next: - Remedio is expected to use the new leadership team to expand globally and deepen enterprise relationships. - The company will likely lean on marketing, partnerships, and customer engagement to push autonomous remediation as a distinct security category. - Remedio’s growth strategy now appears tied to turning its customer base and product claims into broader market share.

The bottom line: - Remedio is adding senior operators at the exact moment it wants to turn technical differentiation into durable category leadership.